Respiratory Monitoring Devices Global Market Report 2024

The respiratory monitoring devices market size has grown rapidly in recent years. It will grow from $1.5 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed during the historical period can be attributed to several factors, including the prevalence of respiratory diseases, an aging population that requires respiratory monitoring, technological advancements in the field, and the use of respiratory monitoring devices in both hospital and homecare settings to improve patient care.

The respiratory monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.39 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to several factors, including the growing awareness of respiratory health, the increasing prevalence of chronic diseases, the expansion of remote patient monitoring, and the integration of wearable technology for respiratory monitoring. Prominent trends in this forecast period encompass the adoption of remote monitoring and telehealth services, the use of connected devices and IoT (Internet of Things) technologies, the application of data analytics and artificial intelligence for enhanced respiratory care, and the development of mobile apps and wearable devices that empower individuals to monitor their respiratory health more effectively.

The growth of the respiratory monitoring devices market is anticipated to be driven by the increasing incidence of chronic respiratory diseases. Conditions like asthma, bronchitis, pneumonia, and others, often resulting from various bacterial and viral infections, are expected to create a greater demand for respiratory monitoring devices. For instance, in June 2023, The Centers for Disease Control and Prevention, a US-based public health agency, reported 142,342 deaths from chronic lower respiratory diseases in 2021. Similarly, The Australian Institute of Health and Welfare, an Australia-based national agency, revealed that nearly one-third of Australians, or 7.5 million people, have been diagnosed with chronic respiratory diseases. These respiratory monitoring devices, including spirometers and pulse oximeters, play a crucial role in monitoring vital respiratory parameters.

The primary categories of respiratory monitoring devices include capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and other related equipment. Capnographs, for example, are devices used to monitor the concentration of carbon dioxide in exhaled air, providing both a numerical readout and a graphical waveform tracing. These devices find applications in various medical contexts, including chronic obstructive pulmonary disease (COPD) management, the diagnosis and monitoring of infectious diseases, asthma treatment, and other respiratory health assessments. These devices are used by a range of end-users, including laboratories, hospitals, and individuals for home use.

The respiratory monitoring devices market research report is one of a series of new reports that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing prevalence of pneumonia is poised to further boost the growth of the respiratory monitoring devices market. Pneumonia, an infection affecting the lungs, can be a severe respiratory condition. Respiratory monitoring devices are instrumental in early detection and management of pneumonia by providing continuous monitoring of respiratory rate and other vital signs. For example, the Centers for Disease Control and Prevention reported 41,309 pneumonia-related deaths in the United States in 2021, with a mortality rate of 12.4 deaths per 100,000 population. Hence, the growing prevalence of pneumonia is a key driver for the respiratory monitoring devices market.

The extended duration required for regulatory approvals of respiratory devices poses a challenge to the growth of the respiratory monitoring devices market. FDA approval processes can take an average of 7.2 months, increasing development costs for device manufacturers and acting as a restraint on market growth. Stringent regulatory policies and approval processes, as enforced by regulatory authorities like the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, are in place to ensure the safety and efficacy of respiratory devices and may impact the market.

Companies in the market are increasingly introducing smart respiratory monitoring devices for the diagnosis and monitoring of respiratory diseases. These smart devices are Bluetooth-enabled and can be linked to smartphones for continuous monitoring of essential respiratory parameters. For instance, in February 2022, Aptar Pharma, a US-based manufacturer of drug delivery systems, unveiled HeroTracker® Sense, a digital respiratory health solution that transforms a standard metered dose inhaler into a smart connected healthcare device. It aids patients in tracking their inhaler usage and adhering to prescribed doses.

Major companies operating in the respiratory monitoring devices market are committed to innovation to offer reliable services to customers. Products like HeroTracker Sense, introduced by AptarGroup, Inc., are designed to address patient inhalation techniques and adherence. This device enhances patient care by collecting healthcare analytics for healthcare providers.

In June 2022, Senzime AB, a US-based patient monitoring systems manufacturer, acquired Respiratory Motion for an initial cash payment of $19 million. This strategic acquisition expands Senzime's product portfolio in the monitoring devices market, strengthening the company's capabilities. Respiratory Motion is a US-based manufacturer of respiratory medical devices.

Major companies operating in the respiratory monitoring devices market include Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, Merck & Co. Inc., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Sirnaomics Inc., Traversa Therapeutics Inc., CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic PLC, Drägerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.

Asia-Pacific was the largest region in the respiratory monitoring devices market in 2023. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.